Search

everythinglearnresearchcommunity

for

Search:↓

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

Finasteride made hair thicker on the back of the head in men with hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

Low-cost dermoscopes can effectively diagnose early female pattern hair loss.

Hospital staff have a higher rate of hair loss than the general population.

Early diagnosis and quick treatment improve life quality for FFA patients.

The technique effectively restores temporal peaks in hair transplants using different hair densities and angles in three zones.

High-frequency ultrasound can effectively visualize and assess hair loss.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Higher substance P levels may cause discomfort in hair loss patients.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.